Written: 2021-02-23 15:39:23 / Updated: 2021-02-23 19:03:06
The benchmark Korea Composite Stock Price Index(KOSPI) fell nine-point-66 points, or zero-point-31 percent, on Tuesday to close at three-thousand-70-point-09. The ...
Written: 2021-02-23 14:49:44 / Updated: 2021-02-23 14:51:04
South Korea's household credit posted a record high in the fourth quarter of last year. According to the latest data by the Bank of Korea(BOK) ...
Written: 2021-02-23 11:32:55 / Updated: 2021-02-23 15:41:53
The head of South Korea's central bank vowed to continue easing monetary policy to bolster the nation's sluggish economy amid a global pandemic. At ...
Written: 2021-02-23 11:14:08 / Updated: 2021-02-23 11:46:19
The policy chief of the ruling Democratic Party(DP) projected that the scope of the government's fourth round of COVID-19 relief payouts would ...
Written: 2021-02-22 15:59:59 / Updated: 2021-02-22 16:08:16
President Moon Jae-in has requested that efforts toward executing a fourth round of COVID-19 payouts to small business owners be expedited with ...
Written: 2021-02-22 15:44:47 / Updated: 2021-02-22 16:45:02
The benchmark Korea Composite Stock Price Index(KOSPI) fell 27-point-87 points, or zero-point-90 percent, on Monday to close at three-thousand-79-point-75. The ...
Written: 2021-02-22 12:49:15 / Updated: 2021-02-22 13:51:15
The South Korean government is considering including more small business owners in its fourth round of COVID-19 relief payments by expanding ...
Written: 2021-02-21 13:17:38 / Updated: 2021-02-21 13:48:33
South Korea witnessed a sharp drop in housing transactions last month. According to data by the Ministry of Land, Infrastructure and Transport ...
Written: 2021-02-19 15:47:54 / Updated: 2021-02-19 18:55:36
The benchmark Korea Composite Stock Price Index(KOSPI) rose 20-point-96 points, or zero-point-68 percent, on Friday to close the week at three-thousand-107-point-62. The ...
Written: 2021-02-19 15:16:45 / Updated: 2021-02-19 15:21:38
Two Kolon Life Science executives have been acquitted of tampering with a key ingredient in a gene therapy drug and submitting a fraudulent report ...
This website uses cookies and other technology to enhance quality of service. Continuous usage of the website will be considered as giving consent to the application of such technology and the policy of KBS. For further details >
